2011
DOI: 10.1007/s00005-011-0130-5
|View full text |Cite
|
Sign up to set email alerts
|

Recent Progress of Shiga Toxin Neutralizer for Treatment of Infections by Shiga Toxin-Producing Escherichia coli

Abstract: Infection with Shiga toxin (Stx)-producing Escherichia coli (STEC), including O157:H7, causes bloody diarrhea and hemorrhagic colitis in humans, occasionally resulting in fatal systemic complications, such as neurological damage and hemolytic-uremic syndrome. Because Stx is a major virulence factor of the infectious disease, a series of Shiga toxin neutralizers with various structural characteristics has been developed as promising therapeutic agents. Most of these agents function to bind to the toxin directly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
26
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 36 publications
(26 citation statements)
references
References 56 publications
(69 reference statements)
0
26
0
Order By: Relevance
“…Inflammation caused by the toxins is believed to be the cause of 11C } the first manifestation of E. coli infection, which is characterized by sudden onset of abdominal pain and severe cramps, followed by diarrhea within 24 hours (Fratamico and Smith 2006), HC typically occurs within 2 to 5 days of ingestion ofSTEC and is often complicated by potentially fatal systemic sequelae such as neurological damage and I IDS, which occur within 2-14 days after the onset of diarrhea (Nishikawa 2011). MUS is defined by the triad of acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia and occurs in about one-tenth to one-fourth of cases {Karmali 2004).…”
Section: Stec Infectionmentioning
confidence: 99%
See 1 more Smart Citation
“…Inflammation caused by the toxins is believed to be the cause of 11C } the first manifestation of E. coli infection, which is characterized by sudden onset of abdominal pain and severe cramps, followed by diarrhea within 24 hours (Fratamico and Smith 2006), HC typically occurs within 2 to 5 days of ingestion ofSTEC and is often complicated by potentially fatal systemic sequelae such as neurological damage and I IDS, which occur within 2-14 days after the onset of diarrhea (Nishikawa 2011). MUS is defined by the triad of acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia and occurs in about one-tenth to one-fourth of cases {Karmali 2004).…”
Section: Stec Infectionmentioning
confidence: 99%
“…Stx are clas sified into two subgroups, Stxl and Stx2. A variant of Stx 1, named Stx 1 c, and several variants of Stx2, named Stx2c, Stx2d, Stx2e, and Stx2f, which differ in their biological activities and association with disease, have been reported (Nishikawa 2011, Thorpe 2004.…”
Section: Stec Infectionmentioning
confidence: 99%
“…Accordingly, several compounds with clustered trisaccharides that can bind to the B subunit with high affinity have been developed and shown to effectively neutralize Stx both in vitro and in vivo (27)(28)(29)(30)(31)(32)(33). These compounds, however, cannot be customized to specific Stx subtypes, because all Stx subtypes recognize the trisaccharide as the natural binding unit.Previously, we developed a library of multivalent peptides exhibiting the clustering effect, from which we identified Stx-neutralizing tetravalent peptides by screening the library for highaffinity binding to the specific receptor-binding sites (33)(34)(35)(36). By targeting Stx2a receptor-binding site 3 or Stx1a site 1, we identified various tetravalent peptides demonstrating remarkable therapeutic potency in both a mouse model of EHEC infection (34, 36) and a nonhuman primate model (19).…”
mentioning
confidence: 99%
“…This type of interaction contributes to the highly selective and potent binding of Stx to target cells, sometimes referred to as the "clustering effect." Accordingly, several compounds with clustered trisaccharides that can bind to the B subunit with high affinity have been developed and shown to effectively neutralize Stx both in vitro and in vivo (27)(28)(29)(30)(31)(32)(33). These compounds, however, cannot be customized to specific Stx subtypes, because all Stx subtypes recognize the trisaccharide as the natural binding unit.…”
mentioning
confidence: 99%
See 1 more Smart Citation